Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Liu, D.S.

Concepts (51)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery5202313281.110 Why?
Oropharyngeal Neoplasms320214921.010 Why?
Lymphatic Metastasis2202128870.770 Why?
Alphapapillomavirus220212190.730 Why?
Papillomavirus Infections3202116400.650 Why?
Mouth Neoplasms220225940.630 Why?
Radiation Oncology120235690.570 Why?
Papillomaviridae3202111410.550 Why?
Carcinoma, Hepatocellular3202123290.450 Why?
Liver Neoplasms3202143530.360 Why?
Lymph Nodes1202134540.320 Why?
Head and Neck Neoplasms4202229210.260 Why?
Carcinoma, Squamous Cell4202240440.240 Why?
Neck Dissection220202000.180 Why?
Australia1202112580.140 Why?
Retrospective Studies62021815140.110 Why?
Aged, 80 and over42022594890.100 Why?
Imaging, Three-Dimensional1202340340.090 Why?
Skin Neoplasms2202158490.080 Why?
Fluorodeoxyglucose F181201820240.080 Why?
Radiopharmaceuticals1201826990.080 Why?
Disease-Free Survival1201868320.070 Why?
Carcinoma, Renal Cell1202131810.070 Why?
Aged520221711170.060 Why?
Young Adult32022598890.060 Why?
Kidney Neoplasms1202142740.060 Why?
Radiotherapy, Adjuvant2202217760.060 Why?
Humans1320237659680.060 Why?
Neoplasm Recurrence, Local2202193730.060 Why?
Smoking1202190810.060 Why?
Middle Aged520222230090.050 Why?
Sensitivity and Specificity12018146520.050 Why?
Adult420222230440.050 Why?
Melanoma1202157190.050 Why?
Radiotherapy Dosage2202028650.050 Why?
Neoplasm Staging32021112060.040 Why?
Male620223636980.040 Why?
Follow-Up Studies12018391930.030 Why?
Female620223961120.030 Why?
Lung Neoplasms12021134510.030 Why?
Carboplatin120187890.030 Why?
Clinical Trials, Phase III as Topic120188780.030 Why?
Radiation Injuries1202011810.030 Why?
Postoperative Care1201814700.020 Why?
Combined Modality Therapy1202085290.020 Why?
Patient Selection1202042550.020 Why?
Prospective Studies22021548020.020 Why?
Survival Rate12018127950.010 Why?
Practice Guidelines as Topic1202074250.010 Why?
Randomized Controlled Trials as Topic12018103830.010 Why?
Treatment Outcome12021651880.010 Why?
Liu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.